On Tuesday, Eli Lilly stock got an upgrade to its Relative Strength (RS) Rating, from 68 to 74.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's proprietary rating tracks share price movement with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research reveals that the best stocks typically have an RS Rating of above 80 in the early stages of their moves. See if Eli Lilly stock can continue to rebound and hit that benchmark.
See How IBD Helps You Make More Money In Stocks
Is Eli Lilly Stock A Buy?
Eli Lilly stock is trying to complete a consolidation with a 384.54 entry. See if the stock can clear the breakout price in heavy trading.
The medical company reported negative growth for both the top and bottom lines last quarter.
Eli Lilly stock earns the No. 2 rank among its peers in the Medical-Diversified industry group. Eli Lilly and Danaher are also among the group's highest-rated stocks.
